<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="ru">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">research-focus</journal-id>
      <journal-title-group>
        <journal-title>Research Focus International Scientific Journal</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Research Focus</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub" publication-format="electronic">2181-3833</issn>
      <publisher>
        <publisher-name>Ilm-fan va innovatsiyalar akademiyasi</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.66073/researchfocus.v3i4.2678</article-id>
      <article-id pub-id-type="other" assigning-authority="relibrary.uz">REL-A-013612</article-id>
      <article-categories>
        <subj-group subj-group-type="oak">
          <subject>14.00.00</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="ru">ОЦЕНКА ЭФФЕКТИВНОСТИ КОРРЕКЦИИ НЕКОНТРОЛИРУЕМОЙ АГ В ПРОФИЛАКТИКЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ</article-title>
        <trans-title-group xml:lang="en">
          <trans-title>ASSESSMENT OF THE EFFECTIVENESS OF CORRECTION OF UNCONTROLLED HYPERTENSION IN THE PREVENTION OF CHRONIC HEART FAILURE</trans-title>
        </trans-title-group>
        <trans-title-group xml:lang="uz">
          <trans-title>SURUNKALI YURAK YETISHMOVCHILIGI PROFILAKTIKASIDA NAZORAT QILINMAYDIGAN AG KORREKSIYASI SAMARADORLIGINI BAHOLASH</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="author">
          <string-name>Юсупова Зумрад Кадамбоевна</string-name>
          <aff>Самаркандский Государственный Медицинский университет, Республика Узбекистан, г. Самарканд</aff>
        </contrib>
      </contrib-group>
      <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2024-05-05">
        <day>05</day>
        <month>05</month>
        <year>2024</year>
      </pub-date>
      <pub-date date-type="collection">
        <year>2024</year>
      </pub-date>
      <volume>3</volume>
      <issue>4</issue>
      <fpage>226</fpage>
      <lpage>232</lpage>
      <permissions>
        <license xlink:href="https://creativecommons.org/licenses/by/4.0">
          <ali:license_ref>https://creativecommons.org/licenses/by/4.0</ali:license_ref>
          <license-p>Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://relibrary.uz/REL-A-013612/"/>
      <abstract xml:lang="ru">
        <p>Несмотря на многочисленные исследования и успехи в лечении артериальной гипертонии, она до сих пор остается убийцей номер один в мире и ее осложнения являются одной из медицинских и социально-экономических проблем, так как приводит к повышению инвалидизации, снижению трудоспособности, высокой смертности этих больных. Удержание под контролем особенно неконтролируемую артериальную гипертензию и предотвращение развития ее осложнений, в частности хронической сердечной недостаточности на сегодняшний день является одной из актуальных проблем кардиологов и врачей первичного звена.</p>
      </abstract>
      <trans-abstract xml:lang="en">
        <p>Despite numerous studies and successes in the treatment of arterial hypertension, it still remains the number one killer in the world and its complications are one of the medical and socio-economic problems, as it leads to increased disability, decreased ability to work, and high mortality in these patients. Keeping especially uncontrolled arterial hypertension under control and preventing the development of its complications, in particular chronic heart failure, is one of the pressing problems of cardiologists and primary care physicians today.</p>
      </trans-abstract>
      <trans-abstract xml:lang="uz">
        <p>Arterial gipertoniyani davolash sohasidagi ko‘plab tadqiqotlar va muvaffaqiyatlarga qaramay, u hanuzgacha dunyoda birinchi raqamli qotil bo‘lib qolmoqda va uning asoratlari tibbiy va ijtimoiy-iqtisodiy muammolardan biri hisoblanadi, chunki u ushbu bemorlarda nogironlikning ortishiga, mehnat qobiliyatining pasayishiga, o‘limning yuqori bo‘lishiga olib keladi. Ayniqsa nazorat qilinmaydigan arterial gipertenziyani nazorat ostida ushlab turish va uning asoratlari, xususan, surunkali yurak yetishmovchiligi rivojlanishining oldini olish bugungi kunda kardiologlar va birlamchi bo‘g‘in shifokorlarining dolzarb muammolaridan biri hisoblanadi.</p>
      </trans-abstract>
      <kwd-group xml:lang="ru">
        <kwd>Гипертоническая болезнь</kwd>
        <kwd>неконтролируемая</kwd>
        <kwd>избыточный вес</kwd>
        <kwd>артериальное давления</kwd>
      </kwd-group>
      <kwd-group xml:lang="en">
        <kwd>Hypertension</kwd>
        <kwd>uncontrolled</kwd>
        <kwd>overweight</kwd>
        <kwd>blood pressure</kwd>
      </kwd-group>
      <kwd-group xml:lang="uz">
        <kwd>Gipertoniya kasalligi</kwd>
        <kwd>nazorat qilinmaydigan</kwd>
        <kwd>ortiqcha vazn</kwd>
        <kwd>arterial bosim</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <ref id="r1">
        <label>1</label>
        <mixed-citation>Agababyan R. Irina, Yusupova K. Zumrad. Possibilities of arterial hypertension control in overweight persons // Journal of Biomedicine and practice. 2023, vol. 8, issue 3, pp.246-251</mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation>Campana E., Cunha V., Glaveckaite S., Gruev I., Lamirault G., Lehmann E., Masi S., Mfeukeu Kuate L., Mishshenko L., Ona D.I.D., Oo M.Z., TautuO.G.F., Vachulova A., Vintila A.M., Wolf J., Zvartau N., Narkiewicz K., Laurent S. The use of single-pill combinations as first-line treatment for hypertension: translating guidelines into clinical practice. J Hypertens 2020 Aug 21. doi: <pub-id pub-id-type="doi">10.1097/HJH.0000000000002598</pub-id>.</mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation>GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environ- mental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1923—1994. doi: 10.1016/ S0140- 6736(18)32225-6.</mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation>Muntner P., Hardy S.T., Fine L.J., Jaeger B.C., Wozniak G., Levitan E.B., Colantonio L.D. Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017- 2018. JAMA 2020;324:1190— 1200. doi: <pub-id pub-id-type="doi">10.1001/jama.2020.14545</pub-id>.</mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation>NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 populationbased measurement studies with 19•1 million participants. Lancet 2017;389(10064):37—55. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(16)31919-5</pub-id>. Erratum in: Lancet 2020;396(10255):886.</mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation>Unger T., Borghi C., Charchar F., Khan N.A., Poulter N.R., Prabhakaran D., Ramirez A., Schlaich M., Stergiou G.S., Tomaszewski M., Wainford R.D., Williams B., Schutte A.E. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 2020;75:1334— 1357. doi: <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.120.15026</pub-id>.</mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation>Vaduganathan M., Claggett B.L., Juraschek S.P., Solomon S.D. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Cardiol 2020;5:576—581. doi: <pub-id pub-id-type="doi">10.1001/jamacardio.2019.6192</pub-id>.</mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation>Y. Wang, X. Nie, L. Chen [et al.]. urden of hypertension in China over the past decades: Systematic analysis of prevalence, treatment and control of hypertension / Y. Wang, X. Nie, L. Chen [et al.]. // European Journal of Preventive Cardiology. - 2015. - Vol. 23, № 8. -P. 792- 800.] <pub-id pub-id-type="doi">10.1177/2047487315617105</pub-id></mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation>Whelton S.P., McEvoy J.W., Shaw L., Psaty B.M., Lima J.A.C., Budoff M., Nasir K., Szklo M., Blumenthal R.S., Blaha M.J. Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors. JAMA Cardiol 2020;5:1011—1018. doi: <pub-id pub-id-type="doi">10.1001/jamacardio.2020.1731</pub-id>.</mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation>Williamson J.D., Supiano M.A., Applegate W.B., Berlowitz D.R., Campbell R.C., Chertow G.M., Fine L.J., Haley W.E., Hawfield A.T., J.H., Kitzman D.W., Kostis J.B., Krousel-Wood M.A., Launer L.J., Oparil S., Rodriguez C.J., Roumie C.L., Shorr R.I., Sink K.M., Wadley V.G., Whelton P.K., Whittle J., Woolard N.F., Wright J.T. Jr, Pajewski N.M.; SPRINT Research Group. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. JAMA 2016;315:2673— 2682. doi: <pub-id pub-id-type="doi">10.1001/jama.2016.7050</pub-id>.</mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation>World Health n-Publication Data, Geneva:Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2012; 23:1296-1310 <pub-id pub-id-type="doi">10.1016/s0149-2918(01)80109-0</pub-id></mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation>Агабабян Ирина Рубеновна and Юсупова Зумрад Кадамбоевна 2023. ВОЗМОЖНОСТИ ЭФФЕКТИВНОГО КОНТРОЛЯ АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ У ЛИЦ С ИЗБЫТОЧНОЙ МАССОЙ ТЕЛА. Research Focus International Scientific Journal. 2, 6 (Jul. 2023), 269–274. <pub-id pub-id-type="doi">10.66073/researchfocus.v2i6.374</pub-id></mixed-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <mixed-citation>Аляви А.Л., Камилова У.К., Расулова З.Д. Диагностика и лечение ХСН (монография). Тошкент. 2016.</mixed-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <mixed-citation>Бадритдинова, М. Н. Распространенность некоторых компонентов метаболического синдрома среди женского населения / М. Н. Бадритдинова, Д. Ш. Кудратова, Д. А. Очилова // Биология и интегративная медицина. - 2016. - № 2. - С. 53-61.</mixed-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <mixed-citation>Козловский В.И., Симанович А.В. Вестник ВГМУ, 2014, Т. 13 (2):6-16</mixed-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <mixed-citation>Качковский, М. А. Возрастные и гендерные показатели распространенности артериальной гипертонии в Промышленном районе города Самары / М. А. Качковский, И. С. Федосеева, Л. М.Назаркина // Дневник Казанской медицинской школы. - 2016. - № 1(11). -С. 11-13.</mixed-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <mixed-citation>Сборник статистических показателей достижения национальных ЦУР в Республике Узбекистан. – Ташкент: Государственный комитет Республики Узбекистан по статистике, 2020 – C.49-58.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
